Evidence map›Paper›PMID 30540658›Full record

SynthesisJournal of hypertension2019

Effects of vasodilating medications on cerebral haemodynamics in health and disease: systematic review and meta-analysis.

Alastair J S Webb

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of hypertension, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Profiling cerebrovascular function in migraine: A systematic review and meta-analysis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Pooled it
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Cerebral perfusion in untreated, controlled, and uncontrolled hypertension.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Effect of drug interventions on cerebral hemodynamics in ischemic stroke patients.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Review
  17. Article
  18. Article
  19. Cerebral arterial pulsatility is linked to hippocampal microvascular function and episodic memory in healthy older adults.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  20. Longitudinal relation between blood pressure, antihypertensive use and cerebral blood flow, using arterial spin labelling MRI.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Alastair J S WebbCentre for Prevention of Stroke and Dementia, John Radcliffe Hospital, University of Oxford, Oxford, UK.
John Radcliffe Hospital · GB

Funding

British Heart Foundation PG/16/38/32080Wellcome Trust 206589/Z/17/Z
6 · The paper itself

Abstract

objectivesVasodilating antihypertensives prevent stroke and potentially cerebral small vessel disease but their effects on cerebrovascular haemodynamics beyond blood pressure lowering are unclear.

methodsWe searched PubMed, Medline, Embase, Cinahl, Psychinfo, Health Business Elite and Health Management Information Consortium for randomized studies of vasodilating medications, compared to no treatment or nonvasodilators, that reported effects on cerebral blood flow (CBF), mean blood flow velocity (MFV) or cerebrovascular reactivity. Absolute and standardized mean differences (SMD) were combined by inverse-variance weighted fixed or random-effects meta-analysis stratified by study design, population characteristics and vasodilator class.

resultsIn 35 studies reporting 57 comparisons, there was a reduction in SBP (-4.13 mmHg, -7.55 to -0.71, P = 0.018) but no change in MFV (ΔMFV 1.11, confidence interval -0.93 to 3.14, P = 0.29, 23 comparisons). MFV increased in patients with underlying conditions (3.41, 0.24 to 6.57, P = 0.04) but not in healthy study participants (-1.27, -5.18 to 2.64, P = 0.68), with no differences by vasodilating drug class. Cerebral pulsatility index was reduced across all studies (Δ pulsatility index -0.04, -0.07 to -0.02, P = 0.001; Δ pulsatility index -SMD -0.32, -0.47 to -0.16, P < 0.001), except in studies reporting responses to single drug doses (Δ pulsatility index 0.00, -0.09 to -0.08, P = 0.93). Despite evidence of reporting and publication bias, there was an apparent consistent reduction in CBF with vasodilators (CBF-SMD -0.24, -0.46 to -0.02, P = 0.03) with a significant increase in cerebrovascular reactivity-SMD (0.48, 0.13-0.83, P = 0.007).

conclusionsDespite reducing SBP, vasodilators did not significantly impair absolute CBF but improved cerebrovascular pulsatility and reactivity, suggesting therapeutic potential in preventing stroke and cerebral small vessel disease.

Indexed as

Antihypertensive AgentsCerebrovascular CirculationHemodynamicsHumansVasodilator AgentsAntihypertensive AgentsVasodilator Agents

Identifiers

PMID30540658
PMCPMC6513078
OpenAlexW2903872456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.